128 related articles for article (PubMed ID: 29939028)
1. Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity.
Bertamino A; Iraci N; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Pepe G; Sala M; Soldovieri MV; Mosca I; Gonzalez-Rodriguez S; Fernandez-Carvajal A; Ferrer-Montiel A; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
J Med Chem; 2018 Jul; 61(14):6140-6152. PubMed ID: 29939028
[TBL] [Abstract][Full Text] [Related]
2. Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities.
Bertamino A; Ostacolo C; Medina A; Di Sarno V; Lauro G; Ciaglia T; Vestuto V; Pepe G; Basilicata MG; Musella S; Smaldone G; Cristiano C; Gonzalez-Rodriguez S; Fernandez-Carvajal A; Bifulco G; Campiglia P; Gomez-Monterrey I; Russo R
J Med Chem; 2020 Sep; 63(17):9672-9694. PubMed ID: 32787109
[TBL] [Abstract][Full Text] [Related]
3. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
Parks DJ; Parsons WH; Colburn RW; Meegalla SK; Ballentine SK; Illig CR; Qin N; Liu Y; Hutchinson TL; Lubin ML; Stone DJ; Baker JF; Schneider CR; Ma J; Damiano BP; Flores CM; Player MR
J Med Chem; 2011 Jan; 54(1):233-47. PubMed ID: 21128593
[TBL] [Abstract][Full Text] [Related]
4. AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.
Lehto SG; Weyer AD; Zhang M; Youngblood BD; Wang J; Wang W; Kerstein PC; Davis C; Wild KD; Stucky CL; Gavva NR
Naunyn Schmiedebergs Arch Pharmacol; 2015 Apr; 388(4):465-76. PubMed ID: 25662185
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.
Journigan VB; Feng Z; Rahman S; Wang Y; Amin ARMR; Heffner CE; Bachtel N; Wang S; Gonzalez-Rodriguez S; Fernández-Carvajal A; Fernández-Ballester G; Hilton JK; Van Horn WD; Ferrer-Montiel A; Xie XQ; Rahman T
ACS Chem Neurosci; 2020 Feb; 11(3):268-290. PubMed ID: 31850745
[TBL] [Abstract][Full Text] [Related]
6. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
Tamayo NA; Bo Y; Gore V; Ma V; Nishimura N; Tang P; Deng H; Klionsky L; Lehto SG; Wang W; Youngblood B; Chen J; Correll TL; Bartberger MD; Gavva NR; Norman MH
J Med Chem; 2012 Feb; 55(4):1593-611. PubMed ID: 22329507
[TBL] [Abstract][Full Text] [Related]
7. Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators.
Bertamino A; Ostacolo C; Ambrosino P; Musella S; Di Sarno V; Ciaglia T; Soldovieri MV; Iraci N; Fernandez Carvajal A; de la Torre-Martinez R; Ferrer-Montiel A; Gonzalez Muniz R; Novellino E; Taglialatela M; Campiglia P; Gomez-Monterrey I
J Med Chem; 2016 Mar; 59(5):2179-91. PubMed ID: 26847872
[TBL] [Abstract][Full Text] [Related]
8. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.
Calvo RR; Meegalla SK; Parks DJ; Parsons WH; Ballentine SK; Lubin ML; Schneider C; Colburn RW; Flores CM; Player MR
Bioorg Med Chem Lett; 2012 Mar; 22(5):1903-7. PubMed ID: 22330635
[TBL] [Abstract][Full Text] [Related]
9. Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.
Bonache MÁ; Martín-Escura C; de la Torre Martínez R; Medina A; González-Rodríguez S; Francesch A; Cuevas C; Roa AM; Fernández-Ballester G; Ferrer-Montiel A; Fernández-Carvajal A; González-Muñiz R
Sci Rep; 2020 Aug; 10(1):14154. PubMed ID: 32843690
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
Sałat K; Filipek B
J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat.
De Caro C; Russo R; Avagliano C; Cristiano C; Calignano A; Aramini A; Bianchini G; Allegretti M; Brandolini L
Br J Pharmacol; 2018 May; 175(10):1691-1706. PubMed ID: 29485712
[TBL] [Abstract][Full Text] [Related]
12. Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR; Gemei M; Lo Monte M; Menegatti N; Fanton M; Pedretti A; Bovolenta S; Nucci C; Molteni A; Rossignoli A; Brandolini L; Taddei A; Za L; Liberati C; Vistoli G
Sci Rep; 2017 Sep; 7(1):10999. PubMed ID: 28887460
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, high-throughput screening and pharmacological characterization of β-lactam derivatives as TRPM8 antagonists.
de la Torre-Martínez R; Bonache MA; Llabrés-Campaner PJ; Balsera B; Fernández-Carvajal A; Fernández-Ballester G; Ferrer-Montiel A; Pérez de Vega MJ; González-Muñiz R
Sci Rep; 2017 Sep; 7(1):10766. PubMed ID: 28883526
[TBL] [Abstract][Full Text] [Related]
14. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
Ma S; G G; Ak VE; Jf D; H H
Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.
Ohmi M; Shishido Y; Inoue T; Ando K; Fujiuchi A; Yamada A; Watanabe S; Kawamura K
Bioorg Med Chem Lett; 2014 Dec; 24(23):5364-8. PubMed ID: 25455182
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of the prototypical TRPM8 agonist icilin.
De Petrocellis L; Ortar G; Schiano Moriello A; Serum EM; Rusterholz DB
Bioorg Med Chem Lett; 2015 Jun; 25(11):2285-90. PubMed ID: 25935641
[TBL] [Abstract][Full Text] [Related]
17. Rational Design of a Modality-Specific Inhibitor of TRPM8 Channel against Oxaliplatin-Induced Cold Allodynia.
Aierken A; Xie YK; Dong W; Apaer A; Lin JJ; Zhao Z; Yang S; Xu ZZ; Yang F
Adv Sci (Weinh); 2021 Nov; 8(22):e2101717. PubMed ID: 34658162
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening.
Iraci N; Ostacolo C; Medina-Peris A; Ciaglia T; Novoselov AM; Altieri A; Cabañero D; Fernandez-Carvajal A; Campiglia P; Gomez-Monterrey I; Bertamino A; Kurkin AV
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216186
[TBL] [Abstract][Full Text] [Related]
19. β-Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models.
Martín-Escura C; Medina-Peris A; Spear LA; de la Torre Martínez R; Olivos-Oré LA; Barahona MV; González-Rodríguez S; Fernández-Ballester G; Fernández-Carvajal A; Artalejo AR; Ferrer-Montiel A; González-Muñiz R
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269831
[TBL] [Abstract][Full Text] [Related]
20. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.
Zhu B; Xia M; Xu X; Ludovici DW; Tennakoon M; Youngman MA; Matthews JM; Dax SL; Colburn RW; Qin N; Hutchinson TL; Lubin ML; Brandt MR; Stone DJ; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2013 Apr; 23(7):2234-7. PubMed ID: 23411075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
